| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Apolipoprotein L1 |
|---|
| Ligand | BDBM615209 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Acute APOL1 Thallium Assay |
|---|
| IC50 | 600±n/a nM |
|---|
| Citation |  CAO, J; COME, JH; DAKIN, LA; DENIS, F; DORSCH, WA; FORTIER, A; HAMEL, M; KRUEGER, EB; LEDFORD, B; NANTHAKUMAR, SS; NICOLAS, O; SAYEGH, C; SENTER, TJ; WANG, T; BRODNEY, M; HU, K; ROSE, P; GAGNON, K; SHI, Y; SHRESTHA, M; MEDEK, A; WITKOS, F INHIBITORS OF APOL1 AND METHODS OF USING SAME US Patent US20230271945 Publication Date 8/31/2023 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Apolipoprotein L1 |
|---|
| Name: | Apolipoprotein L1 |
|---|
| Synonyms: | APOL | APOL1 | APOL1_HUMAN | Apo-L | ApoL-I | Apolipoprotein L | Apolipoprotein L-I | Apolipoprotein L1 |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 43969.63 |
|---|
| Organism: | Homo sapiens |
|---|
| Description: | ChEMBL_120089 |
|---|
| Residue: | 398 |
|---|
| Sequence: | MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTM
DPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLAR
QMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSG
SLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQA
HDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHAS
ASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLH
EGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL
|
|
|
|---|
| BDBM615209 |
|---|
| n/a |
|---|
| Name | BDBM615209 |
|---|
| Synonyms: | 3-[2-(3,4-difluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (129) | US20230271945, Compound 129 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C21H19F2N3O3 |
|---|
| Mol. Mass. | 399.3907 |
|---|
| SMILES | O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccccc12)-c1ccc(F)c(F)c1 |r| |
|---|
| Structure | 
|
|---|
Search and Browse
